Degroof Petercam Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$265K Sell
19,100
-5,100
-21% -$70.7K ﹤0.01% 574
2023
Q4
$253K Buy
+24,200
New +$253K ﹤0.01% 581